8
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Second- and third-trimester serum levels of placental proteins in preeclampsia and small-for-gestational age pregnancies

&
Pages 37-45 | Published online: 10 Aug 2009

References

  • Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986; 93: 1049–59.
  • Ness RB, Roberts JM. Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am J Obstet Gynecol 1996; 175: 1365–70.
  • Austgulen R, Lien E, Vince G, Redman CW. Increased maternal plasma levels of soluble adhesion molecules (ICAM-1, VCAM-1, E-selectin) in preeclampsia. Eur J Obstet Gynecol Reprod Biol 1997; 71: 53–8.
  • Hefler L, Kainz C, Zeisler H, Heinze G, Schatten C, Husslein P et al. Serum levels of leukocyte functional antigen-3 in pregnancy and preeclampsia. Acta Obstet Gynecol Scand 1999; 78: 580–5.
  • Hefler L, Obermair A, Husslein P, Kainz C, Tempfer C. Vascular endothelial growth factor serum levels in pregnancy and preeclampsia. Acta Obstet Gynecol Scand 2000; 79: 77–8.
  • Ellis J, Wennerholm UB, Bengtsson A, Lilja H, Pettersson A, Sultan B et al. Levels of dimethylarginines and cytokines in mild and severe preeclampsia. Acta Obstet Gynecol Scand 2001; 80: 602–8.
  • Huber A, Hefler L, Tempfer C, Zeisler H, Lebrecht A, Husslein P. Transforming growth factor-beta 1 serum levels in pregnancy and pre-eclampsia. Acta Obstet Gynecol Scand 2002; 81: 168–71.
  • Oxvig C, Sand O, Kristensen T, Kristensen L, Sottrup-Jensen L. Isolation and characterisation of circulating complex between human pregnancy-associated plasma protein-A and proform of eosinophil major basic protein. Biochim Biophys Acta 1994; 1201: 415–23.
  • Bischof P. Placental proteins: pregnancy-associated plasma protein A (PAPP-A). Contrib Gynecol Obstet 1984; 12: 41–73.
  • Bischof P. Placental proteins: Schwangerschaftsprotein 1 Contrib Gynecol Obstet 1984; 12: 6–22.
  • Hughes G, Bischof P, Wilson G, Smith R, Klopper A. Assay of placental protein to determine fetal risk. Br Med J 1980; 280: 671–3.
  • Toop K, Klopper A. Concentration of pregnancy-associated plasma protein A (PAPP-A) in patients with pre-eclamptic toxaemia. Placenta 1981; 4: 167–74.
  • Westergaard JG, Teisner B. Pregnancy-associated plasma protein A in normal and abnormal late pregnancy. In: Grudzinskas JG, Teisner B, Seppala M, eds. Pregnancy proteins. Sydney: Academic Press, 1982: 345–54.
  • Bersinger NA, Smaráson AK, Muttukrishna S, Groome NP, Redman CW. Women with pre-eclampsia have increased serum levels of pregnancy-associated plasma protein A (PAPP-A), inhibin A, activin A and soluble E-selectin. Hypertens Preg 2003; 22: 45–55.
  • Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM. Early pregnancy levels of pregnancy-associated plasma protein A and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab 2002; 87: 1762–7.
  • Chapman MG, O’Shea RT, Jones WR, Hillier R. Pregnancy-specific β1-glycoprotein as a screening test for at-risk pregnancies. Am J Obstet Gynecol 1981; 141: 499–502.
  • Obiekwe BC, Sturdee D, Cockrill BL, Chard T. Human placental lactogen in pre-eclampsia. Br J Obstet Gynaecol 1984; 91: 1077–80.
  • Muttukrishna S, Knight PG, Groome NP, Redman CW, Ledger WL. Activin A and inhibin A as possible endocrine markers for preeclampsia. Lancet 1997; 349: 1285–8.
  • Torry DS, Wang HS, Wang TH, Caudle MR, Torry RJ. Pre-eclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol 1998; 179: 1539–44.
  • Su YN, Lee CN, Cheng WF, Shau WY, Chow SN, Hsieh FJ. Decreased maternal serum placenta growth factor in early second trimester and preeclampsia. Obstet Gynecol 2001; 97: 898–904.
  • Muttukrishna S, North RA, Morris J, Schellenberg JC, Taylor RS, Asselin J et al. Serum inhibin A and activin A are elevated prior to the onset of preeclampsia. Hum Reprod 2000; 15: 1640–5.
  • Luckas JM, Meekins JW, Walkinshaw SA, McFadyen IR, Neilson JP. Human chorionic gonadotrophin levels between 15 and 17 weeks in women who subsequently develop preeclampsia. Hypertens Preg 1996; 15: 95–100.
  • Luckas JM, Hawe J, Meekins JW, Neilson JP, Walkinshaw SA. Second trimester serum free beta human chorionic gonadotrophin levels as a predictor of pre-eclampsia. Acta Obstet Gynecol Scand 1998; 77: 381–4.
  • Bakketeig LS, Jacobsen G, Hoffman HJ, Lindmark G, Bergsiø P, Molne K et al. Pre-pregnancy risk factors of small-for-gestational age births among parous women in Scandinavia. Acta Obstet Gynecol Scand 1993; 72: 273–9.
  • Bergsiø P, Hoffman HJ, Davis RO, Goldenberg RL, Lindmark G, Jacobsen G et al. Preliminary results from the collaborative Alabama and Scandinavian study of successive small-for-gestational age births. Acta Obstet Gynecol Scand 1989; 68: 19–25.
  • Marsál K, Persson PH, Larsen T, Lilja H, Selbing A, Sultan B. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr 1996; 85: 843–8.
  • Bersinger NA, Zakher A, Huber U, Pescia G, Schneider H. A sensitive immunoassay for pregnancy-associated plasma protein A (PAPP-A): a possible first trimester method of screening for Down syndrome and other trisomies. Arch Gynecol Obstet 1995; 256: 185–92.
  • Bersinger NA, Brandenberger AW, Birkhauser MH. Endometrial and placental protein markers and ovarian steroids in serum during in-vitro fertilisation cycles. Hum Reprod 1995; 10: 2149–54.
  • Malek A, Sager R, Lang AB, Schneider H. Protein transport across the in vitro perfused human placenta. Am J Reprod Immunol 1997; 38: 263–71.
  • Shenhav S, Gemer O, Sassoon E, Volodarsky M, Peled R, Segal S. Mid-trimester triple test levels in early and late onset severe pre-eclampsia. Prenat Diag 2002; 22: 579–82.
  • Wald NJ, Stone R, Cuckle HS, Grudzinskas JG, Barkai G, Brambati B et al. First trimester concentrations of pregnancy-associated plasma protein A and placental protein 14 in Down’s syndrome. Br Med J 1992; 305: 28.
  • Aitken DA, McKinnon D, Crossley JA, Graham GW, Berry E, Spencer K et al. Changes in the maternal serum concentrations of PAPP-A and SP1 in Down’s syndrome pregnancies between the first and second trimesters. J Med Genet 1994; 31: 170.
  • Bersinger NA, Marguerat P, Pescia G, Schneider H. Pregnancy-associated plasma protein A (PAPP-A): measurement by highly sensitive and specific enzyme immunoassay, importance of first-trimester serum determinations, and stability studies. Reprod Fertil Dev 1995; 7: 1419–23.
  • Shore VH, Wang TH, Wang CL, Torry RJ, Caudle MR, Torry DS. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta 1997; 18: 657–65.
  • Ahmed A, Dunk C, Ahman S, Khaliq A. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PLGF) and soluble Flt-1 by oxygen — a review. Tropho Res (Placenta) 2000; 14: S16–24.
  • Handwerger S, Freemark M. The roles of placental growth hormone and placental lactogen in the regulation of human fetal growth and development. J Pediatr Endocrinol Metab 2000; 13: 343–56.
  • Vatten LJ, Nilsen ST, Odegard RA, Romundstad PR, Austgulen R. Insulin-like growth factor I and leptin in umbilical cord plasma and infant birth size at term. Pediatrics 2002; 109: 1131–5.
  • Bersinger NA, Schneider H, Keller PJ. Synthesis of placental proteins by the human placenta perfused in vitro. Gynecol Obstet Invest 1986; 22: 47–51.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.